jRCTs052240103招募中不适用
Randomized controlled trial comparing root canal filling using resin sealer without gutta-percha point to using conventional technique of root canal filling. (MSSP RCT )
未提供0 个研究点目标入组 384 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 384
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age 0month 0week old over 至 90age 0month 0week old not(—)
- 性别
- All
入选标准
- •(1) Diagnosis of irreversible pulpitis, pulp necrosis, or apical periodontitis based on pulp and periodontal histology and imaging (dental radiographs and dental cone-beam CT).
- •(2) It has been determined that healing is possible by root canal treatment using the standard method.
- •(3) The patient is between 18 and 90 years of age at the time of consent and is capable of consenting.
- •(4) The patient's condition is expected to be stable for at least 12 months from the time consent is obtained.
- •(5) Written consent to participate in this study has been obtained from the patient.
排除标准
- •(1) Has an allergy to raw materials used for root canal filling sealer.
- •(2) With horizontal or vertical root fracture.
- •(3) Perforation difficult to repair and removal of foreign body in root canal difficult to remove.
- •(4) Traffic between periodontal pocket and root canal lesion.
- •(5) History of root tip resection and intentional replantation.
- •(6) It is judged that normal root canal treatment is extremely difficult due to morphological reasons of the root canal, such as dens invaginatus.
- •(7) Patient has a deciduous tooth and a stenotic root canal, and the final magnification of root canal formation is #35 or less.
- •(8) Diagnosed with diabetes mellitus.
- •(9) Patients who are judged to be inappropriate as research subjects by the principal investigator or a sub investigator for other reasons.
结局指标
主要结局
-
Evaluation of periodontal tissue at the root apex using CBCT and clinical symptoms
次要结局
未报告次要终点
研究者
相似试验
尚未招募
2 期
COMPARISION BETWEEN TWO BLOCKS FOR POST OPERATIVE ANALGESIACTRI/2023/06/053548GOVERNMENT MEDICAL COLLEGE, AMRITSAR
招募中
不适用
Second trimester abortion with previous lower segment scarCTRI/2022/01/039442SDM College of medical sciences and hospital
已完成
1 期
The Cancer Molecular Screening and Therapeutics (MoST) Program Substudy addendum 1: PalbociclibCancer - Any cancerCancerACTRN12616000931471niversity of Sydney16
进行中(未招募)
1 期
A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF SINGLE-AGENT LENALIDOMIDE (REVLIMID) IN PATIENTSWITH MANTLE CELL NHL WHO HAVE RELAPSED OR PROGRESSED AFTER TREATMENT WITH BORTEZOMIB OR ARE REFRACTORY TO BORTEZOMIB - NDPATIENTS WITH MANTLE CELL NHL WHO HAVE RELAPSED OR PROGRESSED AFTER TREATMENT WITH BORTEZOMIB OR ARE REFRACTORY TO BORTEZOMIBMedDRA version: 9.1Level: HLTClassification code 10026798Term: Mantle cell lymphomasEUCTR2007-007756-34-ITCelgene Corporation133
招募中
2 期
Cancer Molecular Screening and Therapeutics (MoST) Program Addendum 19 substudies 41-42: SotorasibCancer - Any cancerCancerACTRN12621001690842The University of Sydney32
